ATE386986T1 - Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten - Google Patents

Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten

Info

Publication number
ATE386986T1
ATE386986T1 AT02749828T AT02749828T ATE386986T1 AT E386986 T1 ATE386986 T1 AT E386986T1 AT 02749828 T AT02749828 T AT 02749828T AT 02749828 T AT02749828 T AT 02749828T AT E386986 T1 ATE386986 T1 AT E386986T1
Authority
AT
Austria
Prior art keywords
metabolites
methods
interpret
generate
view
Prior art date
Application number
AT02749828T
Other languages
English (en)
Inventor
Steven Watkins
Original Assignee
Lipomics Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23173313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE386986(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipomics Technologies Inc filed Critical Lipomics Technologies Inc
Application granted granted Critical
Publication of ATE386986T1 publication Critical patent/ATE386986T1/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Bioethics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT02749828T 2001-07-06 2002-07-05 Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten ATE386986T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370401P 2001-07-06 2001-07-06

Publications (1)

Publication Number Publication Date
ATE386986T1 true ATE386986T1 (de) 2008-03-15

Family

ID=23173313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02749828T ATE386986T1 (de) 2001-07-06 2002-07-05 Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten

Country Status (7)

Country Link
US (2) US20040143461A1 (de)
EP (1) EP1417629B1 (de)
AT (1) ATE386986T1 (de)
AU (1) AU2002320316A1 (de)
CA (1) CA2452660A1 (de)
DE (1) DE60225145D1 (de)
WO (1) WO2003005628A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2298181C (en) 2000-02-02 2006-09-19 Dayan Burke Goodnough Non-targeted complex sample analysis
EP1438420B1 (de) * 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Verfahren zur verwendung von quantitativen lipidmetabolondaten
US20040024065A1 (en) * 2002-03-11 2004-02-05 Watkins Steven M. Novel metabolic targets and markers
US7714398B2 (en) * 2002-09-05 2010-05-11 Nanomix, Inc. Nanoelectronic measurement system for physiologic gases and improved nanosensor for carbon dioxide
NZ534751A (en) 2002-03-22 2007-05-31 Phenomenome Discoveries Inc Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
US8346482B2 (en) 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
US20060088860A1 (en) * 2004-09-13 2006-04-27 Lipomics Technologies, Inc. Metabolite markers for weight management
US20060136806A1 (en) * 2004-12-22 2006-06-22 Pharmacyclics, Inc. System and method for analysis of neurological condition
KR100616611B1 (ko) 2005-03-31 2006-08-25 한국과학기술원 Xml을 이용한 대사흐름분석용 정보 시스템 및 그운용방법
US8265877B2 (en) 2005-06-30 2012-09-11 Biocrates Life Sciences Ag Apparatus and method for analyzing a metabolite profile
US7949475B2 (en) * 2005-08-08 2011-05-24 Metabolon Inc. System and method for analyzing metabolomic data
SG165370A1 (en) 2005-09-12 2010-10-28 Phenomenome Discoveries Inc Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
WO2007050318A2 (en) * 2005-10-24 2007-05-03 Duke University Lipidomics approaches for central nervous system disorders
US7491504B2 (en) 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7981399B2 (en) * 2006-01-09 2011-07-19 Mcgill University Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
US7291502B2 (en) * 2006-03-15 2007-11-06 Franco Wayne P Method for performing a non-invasive blood gas test
ES2525345T3 (es) * 2006-03-24 2014-12-22 Metanomics Gmbh Procedimiento de diagnóstico de diabetes de tipo II
JP5421767B2 (ja) 2006-04-10 2014-02-19 ウィスコンシン・アルムニ・リサーチ・ファウンデーション ヒト胚性幹細胞を使用して薬学的化合物および他の化学物質の毒性を評価するための試薬および方法
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
US8498879B2 (en) 2006-04-27 2013-07-30 Wellstat Vaccines, Llc Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of individuals and populations for various uses
EP2029771A4 (de) * 2006-06-12 2010-08-04 Zora Biosciences Oy Verfahren zur diagnose von myopathie
JP2010500566A (ja) 2006-08-08 2010-01-07 テシス バイオサイエンス, インコーポレイテッド 非アルコール性脂肪肝疾患(nafld)および非アルコール性脂肪性肝炎(nash)のマーカーおよびその使用方法
WO2008082712A2 (en) * 2006-08-25 2008-07-10 The Trustees Of Columbia University In The City Of New York Systems and methods for biodosimetry with biochip using gene expression signatures
US7787681B2 (en) * 2006-08-25 2010-08-31 The Trustees Of Columbia University In The City Of New York Systems and methods for robotic transport
EP1923806A1 (de) * 2006-11-14 2008-05-21 Metanomics GmbH Schnelle, metabolomische Analyse und System dafür
WO2008124920A1 (en) * 2007-04-12 2008-10-23 The Governors Of The University Of Alberta Urine based detection of a disease state caused by a pneumococcal infection
CA2724422A1 (en) * 2008-05-28 2009-12-23 Basf Se Means and methods for assessing increased peroxisomal proliferation
US20100070300A1 (en) * 2008-09-18 2010-03-18 Ingenix, Inc. Apparatus, System and Method for Natural History of Disease
US8703424B2 (en) 2010-03-22 2014-04-22 Stemina Biomarker Discovery, Inc. Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
ES2455124T5 (es) 2010-05-05 2018-05-08 Zora Biosciences Oy Biomarcadores lipidómicos para la aterosclerosis y afección cardíaca
JP5662060B2 (ja) * 2010-06-04 2015-01-28 学校法人帝京大学 検出方法
CN103154742B (zh) 2010-06-20 2017-11-21 佐拉生物科学公司 用于鉴定高风险冠状动脉疾病患者的脂质组学标志
US20120078521A1 (en) * 2010-09-27 2012-03-29 General Electric Company Apparatus, system and methods for assessing drug efficacy using holistic analysis and visualization of pharmacological data
US9541565B2 (en) 2011-04-08 2017-01-10 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
KR20140090448A (ko) * 2013-01-09 2014-07-17 한국전자통신연구원 의료 관리 서버 및 그것의 의료 관리 방법
CN105764917B (zh) 2013-09-26 2021-10-08 新加坡国立大学 利用溶血磷脂酰胆碱支架的组合物和方法
CN106537145B (zh) * 2014-04-08 2020-08-25 麦特博隆股份有限公司 用于疾病诊断和健康评估的个体受试者的小分子生物化学特征分析
CN105353607B (zh) * 2015-11-26 2017-10-27 江南大学 一种由数据差异驱动的间歇过程自学习动态优化方法
US11036779B2 (en) * 2018-04-23 2021-06-15 Verso Biosciences, Inc. Data analytics systems and methods
JP2020180826A (ja) * 2019-04-24 2020-11-05 株式会社島津製作所 分析データ解析システム
CN112986425B (zh) * 2021-02-09 2023-07-04 首都医科大学 Pm2.5对脂质代谢影响的检测标志物及应用
CN115112776B (zh) * 2021-03-18 2023-07-04 中国科学院大连化学物理研究所 联合标志物及在诊断心房颤动中应用及诊断试剂或试剂盒
CN115774059A (zh) * 2021-09-07 2023-03-10 中国科学院深圳先进技术研究院 一种阿尔兹海默症生物标志物及其筛选方法和应用
CN116052790B (zh) * 2022-12-21 2026-03-31 贵州医科大学 多场景下复杂体系物质组分分析的方法及系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873726A (en) * 1968-02-14 1975-03-25 Ethyl Corp Method and composition for reducing plasma lipid levels
US3847550A (en) * 1973-03-27 1974-11-12 Atomic Energy Commission Differential chromatographic method
US5075101A (en) * 1990-04-10 1991-12-24 Siguel Edward N Method for diagnosis of fatty acid or lipid abnormalities
US5706603A (en) * 1990-11-16 1998-01-13 E. I. Du Pont De Nemours And Company Production method for corn with enhanced quality grain traits
US5773300A (en) * 1995-05-18 1998-06-30 Cell Therapeutics, Inc. Neoplasia diagnostic method
PT780469E (pt) * 1995-12-21 2001-06-29 Nestle Sa Linhas imortalizadas de celulas derivadas de tecidos cutaneos humanos normais e meios de cultura sem soro adaptados a sua cultura
US5952235A (en) * 1997-04-14 1999-09-14 Case Western Reserve University Detection of teratogen exposure
US6484183B1 (en) * 1997-07-25 2002-11-19 Affymetrix, Inc. Method and system for providing a polymorphism database
ATE280246T1 (de) * 1997-08-15 2004-11-15 Affymetrix Inc Polymorphismuserkennung mit hilfe cluster-analyse
US6222911B1 (en) * 1998-08-05 2001-04-24 Nortel Networks Limited Programmable access carrier selection terminal
US6185561B1 (en) * 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
AU2054000A (en) * 1999-02-26 2000-09-14 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
AU2002233310A1 (en) * 2001-01-18 2002-07-30 Basf Aktiengesellschaft Method for metabolic profiling

Also Published As

Publication number Publication date
WO2003005628A2 (en) 2003-01-16
US20110172926A1 (en) 2011-07-14
EP1417629B1 (de) 2008-02-20
AU2002320316A1 (en) 2003-01-21
WO2003005628A3 (en) 2003-11-06
US20040143461A1 (en) 2004-07-22
DE60225145D1 (de) 2008-04-03
EP1417629A4 (de) 2005-08-17
CA2452660A1 (en) 2003-01-16
EP1417629A2 (de) 2004-05-12

Similar Documents

Publication Publication Date Title
DE60225145D1 (de) Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten
MacDonald et al. Communicating phylogeny: evolutionary tree diagrams in museums
Terzi THE RELATIONSHIP BETWEEN PSYCHOLOGICAL HARDINESS AND PERCEIVED SOCIAL SUPPORT OF UNIVERSITY STUDENTS.
FI20021628A7 (fi) Menetelmä informaation prosessointiin ja informaatiota prosessoiva asiakas
Wathan et al. Online access to quantitative data resources
Salamone So Much Data, So Little Time.
Selman GA Adopts Final Document.
Kumar CAMBODIA'S FIRST VISUAL ARTS OPEN.
Garner Display art from students.
Ellyatt Teaching from the Soul.
Barrons et al. 8th KLOA Conference Report: Our Impression.
Brookes Dallas: Partners for Access.
Randall International interest in CMA/CFM programs grows
through Drying et al. 4th Asia Pacific Drying Conference (ADC 2005), Kolkata, India, December 12–15, 2005 The fourth Asia Pacific Drying Conference (ADC 2005) was held at Science City, Kolkata, the vibrant city of joy of India from 12th to 15th December 2005. It was organized
Humphreys Imagination and historical sense.
Gillon Alastair Vincent Campbell
Schumacher Touched by Disney.
Fringe Addressing workplace issues.
Povell Nancy McCormick Rambusch: A Reflection.
Tomar Remarks on Receiving the Distinguished Service Award.
Parushev Evangelical Scholars address Public Theology.
Carroll The Electromagnetic Internetwork.
Shockley The Whole Musician: Making Music Last a Lifetime.
Purnell Futures in Geographical Education.
Watts Sign Here, Please.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties